NEW YORK, May 12 Delcath Systems, Inc. (Nasdaq: DCTH), a developmental stage specialty pharmaceutical and medical device company focused on oncology, today announced that it will open the NASDAQ stock market on Friday, May 14, 2010. The ceremony at the NASDAQ MarketSite at Times Square in New York City will be broadcast live beginning at 9:22 a.m. Eastern time via the NASDAQ webcam. The live ceremony, including President and Chief Executive Officer Eamonn Hobbs' remarks, can be viewed online at http://www.nasdaq.com/about/marketsitetowervideo.asx. Archived event photos and video will also be available online, at http://www.nasdaq.com/marketsite/marketsite_events.stm.
About Delcath Systems
Delcath Systems, Inc. is a development stage specialty pharmaceutical and medical device company focused on oncology. The Company is investigating a proprietary, patented drug delivery system for the treatment of primary and metastatic liver cancers. Delcath's novel chemosaturation therapy system is testing the delivery of high doses of anti-cancer agents to the liver while controlling the systemic exposure of those agents. In addition to its fully enrolled Phase III metastatic melanoma study, the Company is currently conducting trials to treat other liver cancers. The Company maintains a broad intellectual property portfolio on a worldwide basis including the U.S., Europe, Asia and Canada. For more information, please visit the Company's website at www.delcath.com.
SOURCE Delcath Systems, Inc.